Tanya Siddiqi, M.D.
- Assistant Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation
- Staff Physician
Tanya Siddiqi, M.D.
- Hematopoietic Cell Transplantation
Tanya Siddiqi, M.D., is an accomplished hematologist-oncologist who specializes in diagnosing and treating blood cancers, particularly leukemia and lymphoma. She is also a supervising physician at City of Hope's anticoagulation clinic, which treats patient with blood clotting disorders due to their diseases or treatments.
In addition to her clinical practice, Dr. Siddiqi is also investigating targeted therapies, such as monoclonal antibodies, that can treat these cancers more effectively and with fewer side effects.
Dr. Siddiqi earned her medical degree at Aga Khan University Medical College in Karachi, Pakistan. Afterwards, she completed an internal medicine residency at University of Connecticut Health Center, followed by two fellowships in hematology and hematopoietic stem cell transplantation at Beth Israel Deaconess Medical Center and City of Hope.
- 2010 to present - Assistant clinical professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
- 2013 to present - Supervising physician, Outpatient Anticoagulation Clinic, City of Hope, Duarte, CA
- 2009 to 2010 - Instructor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
- 2001 to 2003 - Research technician, Pulmonary Molecular Biology Laboratory, Baylor College of Medicine, Houston, TX
- 2000 - Aga Khan University Medical College, Karachi, Pakisatan (M.B., B.S.)
- 2009 to 2010 - Fellowship in hematopoietic cell transplantation, City of Hope, Duarte, CA
- 2006 to 2009 - Fellowship in hematology/oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
- 2003 to 2006 - Internship and residency in internal medicine, University of Connecticut Health Center, Farmington, CT
Information listed here is obtained from Pubmed, a public database; City of Hope is not responsible for its accuracy.
- 2012 - Phase I Program Correlative Science Award, City of Hope
- 2009 - Tim Nesvig Lymphoma Foundation grant
- 2008 - American Association for Cancer Research (AACR) Molecular Biology in Clinical Oncology Workshop award
- 2004, 2005, 2006 - Director's letters of recommendation for Excellence in Patient Care, University of Connecticut Health Center